Correction
In an article1 titled “Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure” by Shaoxuan Hu, Yuqin Song, Xiuhua Sun, Liping Su, Wei Zhang, Jing Jia, Ou Bai, Sheng Yang, Rong Liang, Xiaoling Li, Huilai Zhang, Yuhuan Gao, Weijing Zhang, Xiubin Xiao, Huizheng Bao, Ningju Wang, Hanyun Ren, Xinan Cen, Shun'e Yang, Yu Zhao, Yinan Wang, Yalan Wang, Aichun Liu, Jingwen Wang, Yuankai Shi, Ming Yuan, Yufu Li, Xiaohui He, the affiliation in correspondence section and affiliation of Shaoxuan Hu should be corrected:
Shaoxuan Hu1,6, Yuqin Song2, Xiuhua Sun3, Liping Su4, Wei Zhang6, Jing Jia2, Ou Bai5, Sheng Yang1, Rong Liang7, Xiaoling Li8, Huilai Zhang9, Yuhuan Gao10, Weijing Zhang11, Xiubin Xiao11, Huizheng Bao12, Ningju Wang13, Hanyun Ren14, Xinan Cen14, Shun'e Yang15, Yu Zhao16, Yinan Wang17, Yalan Wang18, Aichun Liu19, Jingwen Wang20, Yuankai Shi1, Ming Yuan21, Yufu Li22, Xiaohui He1
1Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China
3Department of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, China
4Department of Hematology, Cancer Hospital of Shanxi Province, Taiyuan, China
5Department of Hematology, The First Hospital of Jilin University, Jilin, China
6Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
7Department of Hematology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China
8Department of Medical Oncology, Liaoning Cancer Hospital and Institute, Shenyang, China
9Department of Medical Oncology, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
10Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
11Department of Medical Oncology, 307 Hospital of Chinese People's Liberation Army, Beijing, China
12Department of Medical Oncology, Jilin Cancer Hospital, Changchun, China
13Department of Medical Oncology, General Hospital of Ningxia Medical University, Yinchuan, China
14Department of Hematology, Peking University First Hospital, Beijing, China
15Department of Medical Oncology, Xinjiang Cancer Hospital, Wulumuqi, China
16Department of Hematology, The General Hospital of Chinese People's Liberation Army, Beijing, China
17Department of Medical Oncology, The People's Hospital of Tangshan City, Tangshan, China
18Department of Medical Oncology, Baotou Cancer Hospital, Baotou, China
19Department of Hematology, The Third Hospital of Harbin Medical University, Haerbin, China
20Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
21Illinois Institute of Technology, Chicago, Illinois
22Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
Correspondence
Xiaohui He, Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
The authors apologize for the error.
